Review: taking Naproxen and Allopurinol together


Summary

Drug interactions are reported among people who take Naproxen and Allopurinol together. This review analyzes the effectiveness and drug interactions between Naproxen and Allopurinol. It is created by eHealthMe based on reports of 1,315 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Naproxen

Naproxen has active ingredients of naproxen. It is often used in pain. (latest outcomes from Naproxen 36,950 users)

Allopurinol

Allopurinol has active ingredients of allopurinol. It is often used in gout. (latest outcomes from Allopurinol 75,375 users)

On Sep, 16, 2016

1,315 people who take Naproxen, Allopurinol are studied.


Number of reports submitted per year:

Naproxen and Allopurinol drug interactions.

Drug effectiveness over time:

Naproxen:
  • < 1 month: 75.0% - (3 of 4 people)
  • 1 - 6 months: 0.0% - (0 of 5 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 33.0% - (1 of 3 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 2 people)
  • 10+ years: 0.0% - (0 of 2 people)
  • not specified: 0.0% - (0 of 0 people)
Allopurinol:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 40.0% - (2 of 5 people)
  • 1 - 2 years: 50.0% - (2 of 4 people)
  • 2 - 5 years: 80.0% - (4 of 5 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Naproxen:
  • female: 0.0% - (0 of 3 people)
  • male: 31.0% - (5 of 16 people)
Allopurinol:
  • female: 33.0% - (1 of 3 people)
  • male: 60.0% - (9 of 15 people)

Drug effectiveness by age:

Naproxen:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 3 people)
  • 40-49: 66.0% - (2 of 3 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 20.0% - (2 of 10 people)
Allopurinol:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 3 people)
  • 40-49: 33.0% - (1 of 3 people)
  • 50-59: 100.0% - (2 of 2 people)
  • 60+: 70.0% - (7 of 10 people)

Most common drug interactions over time *:

< 1 month:
  • dizziness
  • drug ineffective
  • blood creatinine increased
  • hyperkalaemia
  • blood electrolytes abnormal
  • diarrhoea
  • rash pruritic
  • upper gastrointestinal haemorrhage
  • renal failure acute
  • febrile neutropenia
1 - 6 months:
  • dyspnoea
  • gastrointestinal haemorrhage
  • acute lymphocytic leukaemia
  • arrhythmia supraventricular
  • cardiac valve disease
  • cognitive disorder
  • cough
  • dehydration
  • endocarditis
  • haematoma
6 - 12 months:
  • dizziness
  • pruritus
  • blister
  • drug hypersensitivity
  • dyspnoea
  • swelling face
  • blood in stool
  • bone disorder
  • fall
  • fatigue
1 - 2 years:
  • cholecystitis acute
  • erectile dysfunction
  • constipation
  • anaemia
  • asthenia
  • blood iron decreased
  • cerebral infarction
  • cerebrovascular accident
  • decreased appetite
  • duodenal ulcer
2 - 5 years:
  • lip swelling
  • pharyngeal oedema
  • hiatus hernia
  • renal failure
  • blood creatinine increased
  • blood urea increased
  • blood uric acid increased
  • bronchiectasis
  • disseminated intravascular coagulation
  • dysarthria
5 - 10 years:
  • erectile dysfunction
  • syncope
  • abdominal pain
  • anuria
  • chills
  • diarrhoea
  • haemoglobin decreased
  • hyperhidrosis
  • hypotension
  • nausea
10+ years:
  • nephrolithiasis
  • bronchiectasis
  • disseminated intravascular coagulation
  • enterococcal infection
  • escherichia infection
  • hiatus hernia
  • pancreatitis necrotising
  • platelet count decreased
  • renal failure
  • respiratory failure
not specified:
  • dyspnoea
  • dizziness
  • pain
  • nausea
  • fatigue
  • diarrhoea
  • arthralgia
  • anxiety
  • vomiting
  • weight decreased

Most common drug interactions by gender *:

female:
  • dizziness
  • pain
  • nausea
  • weight decreased
  • dyspnoea
  • vomiting
  • urinary tract infection
  • anaemia
  • diarrhoea
  • haemoglobin decreased
male:
  • dyspnoea
  • fatigue
  • nausea
  • pain
  • dizziness
  • arthralgia
  • anxiety
  • diarrhoea
  • interstitial lung disease
  • depression

Most common drug interactions by age *:

0-1:
  • acute psychosis
  • enzyme abnormality
  • pancreatitis
2-9:
  • eye disorder
  • hypersensitivity
10-19:
  • arthralgia
  • back pain
  • bite
  • blood osmolarity increased
  • blood potassium decreased
  • blood test abnormal
  • blood urea decreased
  • blood urea increased
  • blood uric acid decreased
  • blood uric acid increased
20-29:
  • anaemia
  • deep vein thrombosis
  • herpes zoster
  • dyspnoea
  • insomnia
  • asthenia
  • conjunctivitis viral
  • urinary tract infection
  • anxiety
  • cellulitis
30-39:
  • oedema peripheral
  • cough
  • hypocalcaemia
  • hypotension
  • abdominal pain
  • blindness transient
  • stevens-johnson syndrome
  • acute lymphocytic leukaemia
  • arrhythmia supraventricular
  • cardiac valve disease
40-49:
  • nausea
  • dyspnoea
  • eye pruritus
  • eye swelling
  • eyelid oedema
  • dizziness
  • weight decreased
  • cellulitis
  • diarrhoea
  • anaemia
50-59:
  • fatigue
  • dyspnoea
  • completed suicide
  • nausea
  • arthralgia
  • depression
  • dizziness
  • anxiety
  • pain
  • constipation
60+:
  • dizziness
  • pain
  • diarrhoea
  • dyspnoea
  • nausea
  • fatigue
  • hypotension
  • vomiting
  • haemoglobin decreased
  • pyrexia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Naproxen and Allopurinol?


Recent conversations of related support groups:

Can you answer these questions?

More questions for: Naproxen, Allopurinol

You may be interested in these reviews

More reviews for: Naproxen, Allopurinol

On eHealthMe, Naproxen (naproxen) is often used to treat pain. Allopurinol (allopurinol) is often used to treat gout. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.